Overview
Onyekachi Ogbonna is a Hematologist in Beaverton, Oregon. Dr. Ogbonna is highly rated in 4 conditions, according to our data. His top areas of expertise are Childhood Iron Deficiency Anemia, Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), and Childhood Acute Myeloid Leukemia.
His clinical research consists of co-authoring 7 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- POS
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- PPO
- EPO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
15700 SW Greystone Ct, Beaverton, OR 97006
3181 SW Sam Jackson Park Rd, Portland, OR 97239
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
6 Clinical Trials
OHSU Hospital
Stephen Forbes is a Hematologist in Portland, Oregon. Dr. Forbes is highly rated in 22 conditions, according to our data. His top areas of expertise are Mantle Cell Lymphoma (MCL), Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Bone Marrow Transplant, and Bone Marrow Aspiration.
OHSU Hospital
Michael Heinrich is a Hematologist in Portland, Oregon. Dr. Heinrich is highly rated in 18 conditions, according to our data. His top areas of expertise are Gastrointestinal Stromal Tumor, Chronic Myelogenous Leukemia (CML), Mesenchymoma, and Undifferentiated Pleomorphic Sarcoma.
OHSU Hospital
Richard Maziarz is a Hematologist in Portland, Oregon. Dr. Maziarz is highly rated in 26 conditions, according to our data. His top areas of expertise are B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Childhood Acute Myeloid LeukemiaDr. Ogbonna isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Childhood Iron Deficiency AnemiaDr. Ogbonna isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Chronic Myelogenous Leukemia (CML)Dr. Ogbonna isAdvanced. Learn about Chronic Myelogenous Leukemia (CML).
- Philadelphia-Negative Chronic Myeloid Leukemia
- Experienced
- Acute Mountain SicknessDr. Ogbonna isExperienced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Ogbonna isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Ogbonna isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Ogbonna isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Ogbonna isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Ampullary CancerDr. Ogbonna isExperienced. Learn about Ampullary Cancer.